Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

CFDA Said Considering Shortening Oncology Drug INDs To 60 Days

This article was originally published in The Pink Sheet Daily

Executive Summary

China's FDA is acting swiftly to accelerate new drug approvals, this time with a focus on cancer. It is said to be planning a pilot scheme to change the investigational new drug process from an approval to a filing mechanism, and set 60 days as the timeframe.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register